Clinical Trial Update: Rivaroxaban Anticoagulation for Superficial Vein Thrombosis [Phase 3]

View source ↗

Summary

Phase 3 trial update on rivaroxaban for symptomatic superficial vein thrombosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Symptomatic Superficial Vein Thrombosis

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: McMaster University | Conditions: Symptomatic Superficial Vein Thrombosis | Phase 3 | Status: COMPLETED